LoginSignup
PET

PetIQ

Stock
Stock
ISIN: US71639T1060
Ticker: PETQ
US71639T1060
PETQ

Price

Price

Frequently asked questions

What is PetIQ's market capitalization?

The market capitalization of PetIQ is $926.34M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is PetIQ's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for PetIQ is 81.48. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for PetIQ?

PetIQ's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.38. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for PetIQ's stock?

Currently, 5 analysts cover PetIQ's stock, with a consensus target price of $29.00. Analyst ratings provide insights into the stock's expected performance.

What is PetIQ's revenue over the trailing twelve months?

Over the trailing twelve months, PetIQ reported a revenue of $1.13B.

What is the EBITDA for PetIQ?

PetIQ's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $116.56M. EBITDA measures the company's overall financial performance.

What is the free cash flow of PetIQ?

PetIQ has a free cash flow of $11.98M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of PetIQ's stock?

The 5-year beta for PetIQ is 1.74. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does PetIQ have, and what sector and industry does it belong to?

PetIQ employs approximately 1,933 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of PetIQ's shares?

The free float of PetIQ is 27.74M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $926.34M

5Y beta

 1.74

EPS (TTM)

 $0.38

Free Float

 27.74M

P/E ratio (TTM)

 81.48

Revenue (TTM)

 $1.13B

EBITDA (TTM)

 $116.56M

Free Cashflow (TTM)

 $11.98M

Pricing

52W span
$13.81$34.61

Analyst Ratings

The price target is $29.00 and the stock is covered by 5 analysts.

Buy

4

Hold

1

Sell

0

Information

PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.

1,933

Biotechnology & Drugs

Health Care

Identifier

ISIN

US71639T1060

Primary Ticker

PETQ
Join the conversation
Sign upLogin